Systemic lupus erythematosus (SLE) is a prototypic systemic autoimmune diseases, which affects multiple organ systems such as kidney. The imbalance of T-helper 1 (Th1)/ Th2 cells is critical in the pathogenesis of SLE. The T-cell immunoglobulin mucin (TIM) proteins comprise a family of cell surface molecules expressed on T cells that regulate Th1-and Th2-cell-mediated immunity. Recent work has found increased expression of TIM-1 and TIM-3 ligand (galactin-9) mRNA in SLE patients and implied that TIM proteins might be involved in the pathogenesis of SLE. In this study, genotyping of single-nucleotide polymorphisms (SNPs) was performed for TIM-1 (rs1501909 and rs12522248) and TIM-3 (rs9313439 and rs10515746) in 202 SLE patients and 217 healthy individuals in a Chinese population. Results showed no significant differences existed between the patients with SLE and the controls as well as SLE patients with nephritis and those without nephritis, in all four SNPs. The findings suggest that the polymorphisms of TIM gene family might not contribute to SLE susceptibility in the Chinese population. However, it should be noted that the statistical power of our study is relatively low, which likely did not have adequate power to detect the actual correlation between the selected SNPs and SLE susceptibility; moreover, we cannot discard a possible association of other variants within the region covering TIM with SLE as a genetic risk factor, with larger samples in different populations.
Introduction
Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease distinguished by great heterogeneity in clinical manifestations. It involves a diverse array of autoantibody production, complement activation and immune complex deposition, causing tissue and organ damage. Naïve T-helper cells (Th) chiefly differentiate into Th1 or Th2 cells and defects in the appropriate regulation of Th1 and Th2 cell function have been implicated in the pathophysiology of SLE, in which a predominance of Th1 can induce autoimmunity, whereas a Th2 phenotype can be associated with lupus nephritis (LN) (1) . Recent studies have indicated that inappropriate regulation of Th17 cells also participates in the pathogenesis of SLE (2) . The T-cell immunoglobulin mucin (TIM) proteins represent a group of molecules that in concert with T-cell receptor and costimulatory signal to regulate expansion and effector functions of Th1 and Th2 cells (3) .
TIM gene family located in chromosome 5q33.2 consists of three different genes in human beings, TIM-1, TIM-3 and TIM-4, without any other intervening genes (The TIM-2 gene is found only in mice), which encode cell surface glycoproteins with common structural motifs, including a signal peptide, Ig domain, mucin domain, transmembrance region and intercellular tail with phosphorylation sites (4) . TIM protein was initially identified through a screen for Th1-specific and Th2-specific markers. TIM-1 is preferentially expressed in Th2 cells but not Th1 cells and is involved in the development and regulation of Th2-biased immune responses, in contrast with TIM-3, which is expressed on terminally differentiated Th1 cells but not Th2 cells and functions to inhibit aggressive Th1-mediated immune responses (5) . Recent findings demonstrate that TIM-1 during activation and differentiation can positively or negatively costimulate T-cell expansion and effector function. Low-affinity anti-TIM-1 antibodies increased Th2 response and inhibited the development of experimental autoimmune encephalomyelitis (EAE), while high-affinity anti-TIM-1 antibodies increased the production of the proinflammatory cytokines interferon r and interleukin-17 (Th1 and Th17 responses) and the severity of EAE (6) . TIM-3 may also be expressed in Th17 cells but at lower levels than Th1 cells (7). TIM-4, which is expressed in T cells but is exclusively expressed in antigen presenting cells, particularly in mature myeloid-derived dendritic cells and macrophages, is a ligand for TIM-1 (8) .
Although TIM gene family products have been shown to play a role in immune responses, little is known about TIM regulation and the development of SLE. Wang et al. (9) firstly evaluated the expression of TIM-1, TIM-3 and related cytokines in peripheral blood mononuclear cells (PBMCs) in SLE patients and healthy controls and found higher expression of TIM-1 and TIM-3 ligand, galactin-9, in SLE patients, indicating a functional involvement of TIM-1 and TIM-3 pathway in the pathogenesis of SLE (9) . Based on these findings, we have proposed that TIM-3 might be a new therapeutic target for SLE (2) .
TIM gene family may influence the susceptibility to Th1-and Th2-mediated conditions and several studies have suggested that polymorphisms in these genes might be associated with allergic and autoimmune disease in some populations, including rheumatoid arthritis (RA), a Th1/Th17 disease as SLE. We hypothesised that an allele associated with another autoimmune disease has an increased prior probability of being associated with SLE-compared with a random allele chosen from the genome-on the basis of shared pathogenic mechanisms among autoimmune diseases (10) . Furthermore, a recently performed genome-wide association study on SLE in a Chinese Han population identified nine new susceptibility loci including TNIP1 within 5q33.1 and confirmed several loci including 5q33.3, which was previously reported in European populations (11) . Those evidence encouraged us to assess a possible association between the TIM gene family, mapped on chromosome 5q33.2, with SLE.
In this study, we examined both the TIM-1 gene [singlenucleotide polymorphisms (SNPs) rs12522248 in Exon 4 and SNP rs1501909 in intronic] and the TIM-3 gene (SNP rs9313439 in untranslated region (UTR)-3 and SNP rs10515746 in the promoter region) and investigated whether or not genotype and allele frequencies of the TIM gene family confer susceptibility to SLE in a Chinese population.
Materials and methods
Patients and healthy controls A total of 202 patients with SLE (172 female and 30 male) were recruited from Anhui Provincial Hospital and the First Affiliated Hospital of Anhui Medical Universtity. The diagnosis of SLE was established by the presence of four or more American College of Rheumatology (ACR) diagnostic criteria (12) . We excluded patients who had a history of atopy-related disease, such as asthma or allergic rhinitis, because both TIM-1 and TIM-3 have been repeatedly suggested to be linked to susceptibility of asthma and other allergic diseases (13) (14) (15) (16) (17) (18) (19) (20) . Demographic data and clinical data were collected from hospital records or by questionnaire and reviewed by experienced physicians. Renal involvement of SLE was defined according to the ACR criteria, i.e. any one of the following: (i) persistent proteinuria ! 0.5 g/day, (ii) the presence of active cellular casts or (iii) biopsy evidence of LN. Individual disease activity was quantified using the systemic lupus erythematosus disease activity index (SLEDAI) score. Patients were divided into two subgroups according to SLEDAI scores (active ! 10 and inactive , 10) (21). A total of 217 sex-matched healthy blood donors were included as controls, all of whom were without any rheumatologic conditions or any allergic status. The demographic and general characteristics of the study groups are summarised in Table I . EDTA anti-coagulated venous blood samples were collected from all participants. Genomic DNA was extracted from peripheral blood lymphocytes by standard procedures using Flexi Gene DNA kits (Qiagen). All subjects were Chinese from the same area and gave their written consent to participate.
Selection of SNPs investigated TIM gene family products have been shown to play a role in immune responses, so both tag SNPs and those that are likely to affect immune function were included in our study. The TIM-1 gene is highly polymorphic in promoter as well as in coding regions with SNPs and insertion/deletion variants located throughout the gene and more specifically in the Exon 4 coding the functional mucin domain, in which polymorphisms may play an important role in modifying the activity of TIM-1 (16, 22) . SNP rs12522248 (A/G), with a minor allele frequency (MAF) .0.05, mapped to Exon 4 of the TIM-1 gene, which is the main area of importance in this gene locus (23) , results in an amino acid substitution of alanin to threonin and therefore may change the function of TIM-1. An intronic SNP rs1501909 (A/C), with an MAF .0.05, is tagger SNP in TIM-1 gene using haploview 4.2 software.
SNP rs10515746 (G/T) is located in the promoter region of TIM-3 gene, the observed polymorphic allele change could result in a different regulation of TIM-3 function. The change may finally disturb differentiation of Th1/Th2 cells and induce dysregulation of macrophage activation. And SNP rs10515746 of TIM-3 has been linked to RA in a Korean study (24) . SNP rs9313439 (C/G) in UTR-3 is tagger SNP other than intronic SNPs in TIM-3 gene using haploview 4.2 software.
SNP genotyping
Four SNPs selected were genotyped by TaqMan SNP assay using Assay-onDemand probes and primers (Applied Biosystems, Foster City, CA, USA; catalogue numbers C_7494220_10 for rs1501909, C_29499289_10 for rs9313439, C_2082054_20 for rs10515746). And Assay-on-Demand probes and primers for rs12522248 is not available and were pre-designed from Applied Biosystems. Genotyping results were confirmed by DNA sequencing analysis on 20 samples (12 SLE patients and 8 controls), randomly chosen, for SNP rs10515746.
Statistical analysis
All data were analysed using SPSS 10.0 software (SPSS Inc.; 2000). The chisquare test or Fisher's exact test was used to estimate the Hardy-Weinberg equilibrium (HWE) in both SLE patients and healthy controls as well as to compare the genotype and allele frequencies between the two groups. Odds ratios (ORs) and 95% confidence interval (CIs) were also calculated. Adjusted OR with 95% CI for genotype frequency was performed by logistic regression analyses. Haplotype frequency estimation was performed using haploview version 4.2, which uses the Expectation-Maximisation algorithm. All power estimates were done with PAWE software version 1.2 (25, 26) . Probability level ,0.05 in two-tailed test was used as a criterion of significance.
Results
No deviations from HWE were observed in either the patients with SLE or the controls in each polymorphism. The genotype frequency and allele frequency of four SNPs selected in the TIM-1 and TIM-3 genes in SLE patients and control subjects are shown in Table II . Multivariate logistic regression analysis adjusted for sex and age failed to show an association between any of the genotypes and susceptibility to SLE. And no significant differences were either exhibited in the allelic distributions between them.
Two hundred and two patients with SLE were included in the present study, 83 of whom were patients with LN. We compared the distribution of genotype and allelic frequencies between the patients with LN and SLE patients without nephritis. No statistical differences were detected (Table III) .
To determine whether polymorphisms in TIM-1 and TIM-3 genes in SLE patients are associated with disease activity, we subdivided the patients into active group (n 5 94) and inactive group (n 5 105) according to clinical disease activity. As was shown in Table IV , there was no significant differences in genotype and allele frequency for each polymorphism between the two groups.
We also analysed the haplotypes of TIM-1-TIM-3 and determined three main haplotype: AGCG, CACG and CGCG ( Table V ) and found that the frequencies in cases were not significantly different from those in controls, with respect to the three haplotypes.
Power calculation was performed assuming an allele frequency for SLE patients and controls as follows: of 38.1 and 40.7% (rs1501909 C), of 20.2 and 22.1% (rs12522248 A), of 97.5 and 97.7% (rs9313439 C) and of 98.8 and 98.6% (rs10515746 G), respectively, and a Type 1 error rate of 5%. On the basis of these assumptions, we estimate that our study has a statistical power of only 12.0, 10.3, 5.4 and 5.7%, respectively, to detect a true-positive association.
Discussion
SLE has been revealed to be likely both a Th1-and Th17-mediated disease (2) and increased expression of TIM-1 and TIM-3 ligand (galactin-9). mRNA have been found in SLE patients compared with healthy controls (9). What's more, TIM gene family are located on the chromosomic region 5q33.2, a region that has been repeatedly linked with susceptibility to RA, autoimmune thyroid disease, Type 1 diabetes and Crohn's disease (22) . Additionally, the two loci adjacent to 5q33.2, 5q33.1 and 5q33.3 have shown association with SLE in a Chinese population (11) . Therefore, we considered these genes, which are involved in the regulation of CD4þT-cell differentiation, as potential candidates to SLE susceptibility. Four SNPs of the TIM-1 and TIM-3 genes, selected on the basis of their relatively higher allele frequencies and availability, were analysed in 202 Chinese SLE patients and 217 matched controls in the present study. Nevertheless, none of these SNPs showed a significant association with SLE, which is in agreement with findings by Garcia-Lozano et al. (22) . They examined a Spanish population and demonstrated no differences in the distribution of genotypes of TIM-1 in SLE patients comparing with the control group (22) . Even though the SNP rs10516746 frequency observed in SLE were similar to those described in Korean patients with RA (24), we failed to detect significant association between rs10515746 and SLE, as RA. And genotype and allele frequencies for SNP rs12522248 varied between our patients and Tyrolean Caucasian patients with multiple sclerosis (MS) (23) . Although it has been shown that TIM-1 expression was related to active clinical phases in SLE (9), no significant association was observed for either TIM-1 or TIM-3 polymorphism with different clinical phases of SLE in our population. As the first discovered TIM gene, TIM-1 was initially identified as kidney injury molecule 1 and hepatitis A virus cellular receptor (HAVCR) 1, which encodes receptors selectively expressed on Th2 cells and associated with the development of Th2-biased immune responses. However, a high mRNA TIM-1 production could also increase Th1 and Th17 responses (22) . And TIM-3 (also known as HAVCR2) was the first surface molecule that specifically identifies Th1 cells in both mice and human and interacts with its ligand, galactin-9 to regulate Th1 responses. Several other cell types may also express TIM-3, such as cytotoxic CDþ8 T cells, Th17, regulatory T cell, monocytes, dendritic cells, microglia and mast cells (27) . Seki et al. (28) have found that galectin-9 ameliorates collageninduced arthritis by suppressing the generation of Th17, promoting the induction of regulatory T cells.
The balance of Th1 and Th2 cells regulates the immune system under normal conditions and is vital in the pathogenesis of allergic diseases, such as asthma, as well as of autoimmune diseases including RA, MS and SLE. Many studies have demonstrated that TIM proteins influences chronic autoimmune diseases and polymorphisms in TIM gene family were hypothesised to contribute to TIM proteins expression and might be involved in the etiopathogenesis of autoimmune diseases. And some work have been performed to investigate whether genetic variations in TIM-1 and TIM-3 are associated Fisher's exact test.
Association of TIM gene family polymorphisms with SLE
with the susceptibility to several autoimmune diseases but with controversial results. The polymorphisms within coding region of cytokine gene have influence on protein structure and expression by the inhibitions of binding to specific cytokine receptors and initiating signal transduction and second signal pathways within the target cell or molecules. Accordingly, these variations might have influence on the susceptibility to allergic or autoimmune response (29) . Therefore, the 5383_5397ins/del and the 5509_5511CAA ins/del in TIM-1 gene (10, 17, 18, 22, 23, (29) (30) (31) (32) (33) , as well as SNP rs10515746 in TIM-3 gene, were the most studied (13, 34) . An association between TIM-1 polymorphism and RA in the Spanish, North American and Korean populations, but not in the Swedish population, was observed (10,22,30,35) . Chae et al. (24) provided support for an association of RA with TIM-3 polymorphism in the Korean population, in which SNP rs10516746 was included. However, polymorphisms in TIM gene family showed no association with other autoimmune diseases, even though their proteins had been reported to play a role in the corresponding disease. TIM-1 and TIM-3 were reported to differentially expressed by mononuclear cells in cerebrospinal fluid of MS patients and therefore may be involved in different phases of the pathogenesis of MS (23) . Significantly, lower expression of TIM-3 was revealed in T-cell clones obtained from patients with MS as compared with normal controls and a defect in TIM-3 immunoregulation in MS patients was indicated (36, 37) . However, even fine mapping of TIM-1 (including SNP rs12522248) failed to detect a significant association with MS in Tyrolean Caucasian population (23) . Although treatment with TIM-3-specific monoclonal antibodies accelerated the onset of disease in the nonobese diabetes mouse with spontaneous insulin-dependent diabetes, while blockade of the TIM-3 pathway significantly accelerates diabetes and prevents the acquisition of transplantation tolerance induced by costimulatory blockade, TIM-3 polymorphism (including SNP rs10515746) was not associated with German Type 1 diabetes in a family-based association analysis (38) . Compared with healthy controls in a Chinese study, significantly decreased TIM-3 mRNA expression was demonstrated in PBMCs from patients with idiopathic thrombocytopenic purpura (ITP), while genetic variation within TIM-3 gene did not influence the risk of developing ITP, and SNP rs10515746 polymorphism was also included (39) . Ascertainment biases, population substructure and other factors might contribute to the discrepancies observed in the association studies (22) .
Those association studies above investigated TIM-1 or TIM-3 separately, while our study determined TIM-1 and TIM-3 simultaneously in the same group of patients since abnormal regulation of Th1, Th2 and Th17 cells could all contribute to the onset of autoimmune diseases such as SLE. Furthermore, most of the previous related study were analysed by polymerase chain reaction and restriction fragment length polymorphism, while our study were conducted by TaqMan SNP assays, which use the 5#nuclease assay for amplifying and detecting specific SNP alleles in purified genomic DNA samples and provide optimised assays for genotyping SNPs.
In conclusion, we found no association of TIM-1 and TIM-3 gene polymorphisms with susceptibility to SLE in the Chinese population. However, it should be noted that the statistical power of our study is relatively low, which may not be sufficient to detect, the actual correlation between these SNPs and SLE susceptibility. Nonetheless, the relevant data are very limited and much of the incompatibility remains to be resolved, so we cannot discard a possible association of other variants within the region covering TIM with SLE as a genetic risk factor. Further studies with larger samples in different populations are needed to determine the links between TIM polymorphisms and the development of SLE.
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